Investor Relations

Marrone Bio Innovations Inc. (MBI) (NASDAQ: MBII) provides biological based solutions for agricultural crops, turf protection, seed treatment, plant health and waterway systems. As a leader in alternatives to conventional pesticides, MBII has a proven go-to-market strategy and remains on the cutting edge of developing the types of biological products in which today’s farmers are increasingly interested.

Canaccord Genuity AgriFood Tech Innovation Virtual Forum

December 3, 2020

Marrone Bio Innovations will present at the Canaccord Genuity AgriFood Tech Innovation Virtual Forum at 1:30 p.m. Eastern Time

Latest Video Update

August 2020

Newly appointed CEO, Kevin Helash, shares his background, what brought him to Marrone Bio Innovations and insights on the company's Q2 earnings results.

MBII Stock

Press Releases

Marrone Bio Innovations’ New Plant Health Product, Pacesetter®, Delivers a Six to One Return on Investment for Corn and Soybean Farmers

February 8, 2021Press Releases

Marrone Bio Files $90 Million Shelf Registration Statement

February 8, 2021Press Releases

Marrone Bio Innovations Issues Shareholder Letter

February 3, 2021Press Releases

Marrone Bio Appoints Sue Cheung New Chief Financial Officer

January 28, 2021Press Releases

Global Adoption of Biologicals Accelerates as Marrone Bio’s Grandevo® WDG Bioinsecticide is Approved for Use in New Zealand, Chile and on Hemp in the U.S.

January 14, 2021Press Releases

Marrone Bio Innovations Announces Effectiveness of Form S-3 Resale Registration Statement

January 5, 2021Press Releases

Presentations & Interviews

See Presentations Library for more.

Settlement of Shareholder Derivative Lawsuits

Notice of Pendency of Proposed Settlement of Stockholder Derivative Action

Stipulation of Settlement